Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
No Thumbnail Available
Date
2020
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
[No abstract available]
Description
Keywords
Allergists , Asthma , Betacoronavirus , CD8-Positive T-Lymphocytes , Coronavirus Infections , Eosinophils , Humans , Immunoglobulin E , Immunoglobulin M , Infection Control , Pandemics , Pneumonia, Viral , Rhinitis, Allergic , Sublingual Immunotherapy , Th2 Cells , allergen , immunoglobulin E , immunoglobulin M , Article , coronavirus disease 2019 , desensitization , human , immunological tolerance , immunologist , pandemic , practice guideline , priority journal , risk assessment , Severe acute respiratory syndrome coronavirus 2 , allergic rhinitis , asthma , Betacoronavirus , CD8+ T lymphocyte , complication , Coronavirus infection , eosinophil , genetics , immunology , infection control , metabolism , pandemic , procedures , psychology , sublingual immunotherapy , Th2 cell , virology , virus pneumonia